Since the 2023 financing round, Flare’s lead program FX-909 has moved into a phase 1 clinical trial for patients with ...

Seventy-two years after the Roche family opened a meat market that grew into a Massachusetts supermarket chain, the family is ...

Roche Bros. Supermarkets is selling controlling interest to one of its suppliers. The family-owned retailer that operates 20 stores in Massachusetts entered into agreement with Bozzuto's Inc., a deal ...

Flare Therapeutics will lead discovery and preclinical activities targeting multiple transcription factor targets in oncology, while Roche will pursue the further preclinical and clinical development ...

Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision ...

With the formation of a new strategic partnership, Dyno Therapeutics is responsible for the development of novel AAV capsids.

The family that started the Roche Bros. supermarket chain over 70 years ago is selling a controlling interest in the local company to its longtime supplier in Connecticut. The Mansfield-based grocer ...

The South African Health Products Regulatory Authority (Sahpra ... Other pharmaceutical players such as Roche, Amgen, Pfizer, ...

said Roche "is committed to deliver healthcare innovations that significantly improve patients' lives in the country while ...

Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

The brand, alongside a committee of board-certified dermatologists, awards winners for their research and provides grants to ...

New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel and Elecsys ptau181 for ruling out Alzheimer’s disease related amyloid pathology with very good accuracy. In the largest ...